Literature DB >> 11893011

Vascular endothelial growth factor concentrations in follicular fluid obtained from IVF-ET patients: a comparison of hMG, clomiphene citrate, and natural cycle.

Osamu Tokuyama1, Yoshihiro Nakamura, Ayako Muso, Yuji Fujino, Osamu Ishiko, Sachio Ogita.   

Abstract

PURPOSE: Evaluation of vascular endothelial growth factor (VEGF) concentrations of follicular fluid (FF) in accordance with an ovarian stimulation protocol and ovarian response.
METHODS: The subjects of this study were 38 patients undergoing IVF-ET in our hospital. They were divided into three groups according to ovarian stimulation protocols; Group 1: hMG cycles (n = 19), Group 2: clomiphene citrate cycles (n = 10), Group 3: natural cycles (n = 9). They reclassified into three groups according to the number of oocytes harvested. VEGF concentration was measured in FF, employing ELISAs.
RESULTS: Group 1 shows lower VEGF concentrations in FF than Group 2 or Group 3. Excluding high responders from Group 1, no difference was found among these three groups. As for the reclassified groups, group of highest number of oocytes havested showed lowest VEGF concentrations in FF.
CONCLUSIONS: VEGF concentrations in FF might negatively correlate with the number of follicles, irrespective of the ovulation induction protocol.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11893011      PMCID: PMC3455670          DOI: 10.1023/a:1014006605859

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  13 in total

Review 1.  Severe OHSS: An 'epidemic' of severe OHSS: a price we have to pay?

Authors:  Y Abramov; U Elchalal; J G Schenker
Journal:  Hum Reprod       Date:  1999-09       Impact factor: 6.918

Review 2.  Molecular and biological properties of the vascular endothelial growth factor family of proteins.

Authors:  N Ferrara; K Houck; L Jakeman; D W Leung
Journal:  Endocr Rev       Date:  1992-02       Impact factor: 19.871

Review 3.  The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.

Authors:  B Rizk; M Aboulghar; J Smitz; R Ron-El
Journal:  Hum Reprod Update       Date:  1997 May-Jun       Impact factor: 15.610

Review 4.  Angiogenesis in reproductive tissues.

Authors:  J K Findlay
Journal:  J Endocrinol       Date:  1986-12       Impact factor: 4.286

5.  Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome.

Authors:  C D Chen; H F Chen; H F Lu; S U Chen; H N Ho; Y S Yang
Journal:  Hum Reprod       Date:  2000-05       Impact factor: 6.918

6.  Vascular endothelial growth factor production by human luteinized granulosa cells in vitro.

Authors:  A Lee; L K Christenson; P E Patton; K A Burry; R L Stouffer
Journal:  Hum Reprod       Date:  1997-12       Impact factor: 6.918

7.  Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome?

Authors:  E Geva; A Amit; J B Lessing; L Lerner-Geva; Y Daniel; I Yovel; F Azem; V Barak
Journal:  J Reprod Med       Date:  1999-02       Impact factor: 0.142

8.  Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome.

Authors:  Y Abramov; V Barak; B Nisman; J G Schenker
Journal:  Fertil Steril       Date:  1997-02       Impact factor: 7.329

9.  Human follicle fluid vascular endothelial growth factor concentrations are correlated with luteinization in spontaneously developing follicles.

Authors:  J N Anasti; S N Kalantaridou; L M Kimzey; M George; L M Nelson
Journal:  Hum Reprod       Date:  1998-05       Impact factor: 6.918

10.  Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome.

Authors:  N McClure; D L Healy; P A Rogers; J Sullivan; L Beaton; R V Haning; D T Connolly; D M Robertson
Journal:  Lancet       Date:  1994-07-23       Impact factor: 79.321

View more
  2 in total

1.  The Higher Response of Vascular Endothelial Growth Factor and Angiotensin-II to Human Chorionic Gonadotropin in Women with Polycystic Ovary Syndrome.

Authors:  Junwei Qu; Yena Che; Pei Xu; Yanjie Xia; Xiaoke Wu; Yong Wang
Journal:  Int J Fertil Steril       Date:  2015-02-07

2.  Impact of exogenous gonadotropin stimulation on circulatory and follicular fluid cytokine profiles.

Authors:  N Ellissa Baskind; Nicolas M Orsi; Vinay Sharma
Journal:  Int J Reprod Med       Date:  2014-11-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.